首页 蛋白库 基因库 产品 会员服务
位置：首页 > 产品库 > Lansoprazole sodium
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
Lansoprazole sodium
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
Lansoprazole sodium图片
CAS NO:226904-00-3
包装与价格：
包装价格(元)
10mM (in 1mL DMSO)询价
1g询价

PPI/cytochrome P450 inhibitor
Cas No.226904-00-3
别名兰索拉唑钠
化学名sodium;2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]benzimidazol-1-ide
Canonical SMILESCC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCC(F)(F)F.[Na+]
分子式C16H13F3N3NaO2S
分子量391.34
溶解度≥ 15.05mg/mL in Ethanol
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Lansoprazole sodium is a proton-pump inhibitor (PPI) and also can inhibit cytochrome P450 [1].

Lansoprazole sodium is a substituted benzimidazole and has been widely used as acid inhibitory agent for treatment of disorders related to gastric acid secretion. Lansoprazole sodium has been exhibited to inhibit stomach acid by blocking the H+/K+ATPase system at the secretory surface of gastric parietal cells. As the human P450 enzymes including CYP2C9,2C19, 2D6 and 3A4, in addition, Lansoprazole sodium has been reported to have the competitively inhibitory effect on the activity of CYP2C9 in HLM with a Ki value of 21μM. Lansoprazole sodium has been found to be potent CYP2C19 inhibitor with a Ki value of about 1μM in both HLM and rCYP2C19 tests. Besides, Lansoprazole sodium has been revealed to inhibit the activities if CYP2D6 and CYP3A4 with IC50 values of both>200μM [1].

References:
[1] Li XQ1, Andersson TB, Ahlstrom M, Weidolf L.Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004 Aug;32(8):821-7.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024